benphothiamine has been researched along with Disease Models, Animal in 10 studies
benfotiamine : A thioester that is a synthetic analogue of thiamine obtained by acylative cleavage of the thiazole ring and O-phospohorylation.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The neurodegeneration of Alzheimer's disease (AD) affects not only brain structures associate with cognition early in the progression of the disease, but other areas such as the hypothalamus, a region involved in the control of metabolism and appetite." | 1.72 | Benfotiamine protects against hypothalamic dysfunction in a STZ-induced model of neurodegeneration in rats. ( Cardinali, CAEF; Donato, J; Gonçalves, AC; Guerra-Shinohara, EM; Kleinridders, A; Leboucher, A; Lima, GCA; Moraes, RCM; Portari, GV; Torrão, ADS, 2022) |
| " The present data suggest that thiamine precursors with high bioavailability might be useful as a complementary therapy in several neuropsychiatric disorders." | 1.46 | Thiamine and benfotiamine prevent stress-induced suppression of hippocampal neurogenesis in mice exposed to predation without affecting brain thiamine diphosphate levels. ( Anthony, DC; Bazhenova, N; Bettendorff, L; Caron, N; Coumans, B; Gorlova, A; Lakaye, B; Malgrange, B; Markova, N; Pavlov, D; Sambon, M; Shevtsova, E; Strekalova, T; Svistunov, A; Vignisse, J; Wins, P, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yako, H | 1 |
| Niimi, N | 1 |
| Kato, A | 1 |
| Takaku, S | 1 |
| Tatsumi, Y | 1 |
| Nishito, Y | 1 |
| Kato, K | 1 |
| Sango, K | 1 |
| Moraes, RCM | 1 |
| Lima, GCA | 1 |
| Cardinali, CAEF | 1 |
| Gonçalves, AC | 1 |
| Portari, GV | 2 |
| Guerra-Shinohara, EM | 1 |
| Leboucher, A | 1 |
| Donato, J | 1 |
| Kleinridders, A | 1 |
| Torrão, ADS | 1 |
| Ahmed, LA | 1 |
| Hassan, OF | 1 |
| Galal, O | 1 |
| Mansour, DF | 1 |
| El-Khatib, A | 1 |
| Vignisse, J | 3 |
| Sambon, M | 1 |
| Gorlova, A | 1 |
| Pavlov, D | 1 |
| Caron, N | 1 |
| Malgrange, B | 1 |
| Shevtsova, E | 1 |
| Svistunov, A | 2 |
| Anthony, DC | 2 |
| Markova, N | 2 |
| Bazhenova, N | 2 |
| Coumans, B | 1 |
| Lakaye, B | 1 |
| Wins, P | 1 |
| Strekalova, T | 2 |
| Bettendorff, L | 3 |
| Tapias, V | 1 |
| Jainuddin, S | 1 |
| Ahuja, M | 1 |
| Stack, C | 1 |
| Elipenahli, C | 1 |
| Gerges, M | 1 |
| Starkova, N | 1 |
| Xu, H | 1 |
| Starkov, AA | 1 |
| Hushpulian, DM | 1 |
| Smirnova, NA | 1 |
| Gazaryan, IG | 1 |
| Kaidery, NA | 1 |
| Wakade, S | 1 |
| Calingasan, NY | 1 |
| Thomas, B | 1 |
| Gibson, GE | 1 |
| Dumont, M | 1 |
| Beal, MF | 1 |
| Ovidio, PP | 1 |
| Deminice, R | 1 |
| Jordão, AA | 1 |
| Lesch, KP | 1 |
| Katare, RG | 1 |
| Caporali, A | 1 |
| Oikawa, A | 1 |
| Meloni, M | 1 |
| Emanueli, C | 1 |
| Madeddu, P | 1 |
| Karachalias, N | 1 |
| Babaei-Jadidi, R | 1 |
| Rabbani, N | 1 |
| Thornalley, PJ | 1 |
| Wu, S | 1 |
| Ren, J | 1 |
10 other studies available for benphothiamine and Disease Models, Animal
| Article | Year |
|---|---|
Role of pyruvate in maintaining cell viability and energy production under high-glucose conditions.
Topics: Adenosine Triphosphate; Animals; Cell Line; Cell Survival; Citric Acid Cycle; Diabetic Nephropathies | 2021 |
Benfotiamine protects against hypothalamic dysfunction in a STZ-induced model of neurodegeneration in rats.
Topics: Alzheimer Disease; Animals; Disease Models, Animal; Rats; Streptozocin; Thiamine | 2022 |
Beneficial effects of benfotiamine, a NADPH oxidase inhibitor, in isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Biomarkers; Cardiotoxins; Disease Models, Animal; Electrocardiography; Enzyme Inhibitors; H | 2020 |
Thiamine and benfotiamine prevent stress-induced suppression of hippocampal neurogenesis in mice exposed to predation without affecting brain thiamine diphosphate levels.
Topics: Animals; Dentate Gyrus; Disease Models, Animal; Glycogen Synthase Kinase 3; Hippocampus; Male; Mice, | 2017 |
Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy.
Topics: Amyloid beta-Peptides; Animals; Antioxidant Response Elements; Brain; Disease Models, Animal; Humans | 2018 |
Protective effect of treatment with thiamine or benfotiamine on liver oxidative damage in rat model of acute ethanol intoxication.
Topics: Alcoholic Intoxication; Animals; Disease Models, Animal; Liver Diseases; Male; Oxidative Stress; Rat | 2016 |
Thiamine and benfotiamine improve cognition and ameliorate GSK-3β-associated stress-induced behaviours in mice.
Topics: Animals; Avoidance Learning; Brain; Cognition Disorders; Conditioning, Psychological; Disease Models | 2017 |
Vitamin B1 analog benfotiamine prevents diabetes-induced diastolic dysfunction and heart failure through Akt/Pim-1-mediated survival pathway.
Topics: Analysis of Variance; Animals; Apoptosis; Blood Flow Velocity; Blotting, Western; Carrier Proteins; | 2010 |
Increased protein damage in renal glomeruli, retina, nerve, plasma and urine and its prevention by thiamine and benfotiamine therapy in a rat model of diabetes.
Topics: Adjuvants, Immunologic; Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Kidney Glo | 2010 |
Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha.
Topics: Adjuvants, Immunologic; Analysis of Variance; Animals; Blood Glucose; Diabetes Mellitus, Experimenta | 2006 |